1. Articles in category: Other Business News

    25-48 of 863 « 1 2 3 4 5 ... 34 35 36 »
    1. New study on non-invasive diagnosis of non-melanoma skin cancer with Melanoma Institute of Australia

      New study on non-invasive diagnosis of non-melanoma skin cancer with Melanoma Institute of Australia

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, has commenced a clinical study to investigate the use of OCT to diagnose basal cell carcinoma in collaboration with the Melanoma Institute of Australia using Michelson’s Diagnostics VivoSight system. The study, run by Dr Pascale Guitera FACD PhD, will evaluate VivoSight’s ability to triage lesions which are superficial enough to be treated non-invasively and monitor the success, or otherwise, of non-invasive therapies. The study is designed to determine the potential to change clinical practice towards more non-invasive treatments of basal cell carcinoma ...

      Read Full Article
    2. Intraocular lenses and Japan tax hike drive Meditec growth

      Intraocular lenses and Japan tax hike drive Meditec growth

      In his letter to shareholders, Monz also highlighted the recent introduction of the first ophthalmic surgery microscope to feature an integrated optical coherence tomography (OCT) camera as evidence of the company’s ongoing innovation. “The unique combination of two established Zeiss gold standards means we can now offer surgeons more comprehensive visualization during surgery, which enables better treatment results,” Monz wrote. Fierce competition in diagnostics Though growing fast, the surgical ophthalmology business unit remains Meditec’s smallest, accounting for €73.4 million of sales in the six months to the end of March. Multifocal and premium toric lenses developed recently ...

      Read Full Article
    3. Thorlabs expands global operations to Montreal

      Thorlabs expands global operations to Montreal

      For production of fiber-based systems for OCT and more, also to be sales and support center for Canada. Now in Canada: Alex Cable Founder & President Thorlabs. Thorlabs , headquartered in Newton, NJ, USA, has announced that it has added a new R&D and manufacturing site to its global operations. Based in Montreal, Thorlabs Canada ULC will focus on the development and production of a range of innovative passive fiber-based optical components. The opening of the Canadian operation expands the company's geographical footprint, which now includes 13 manufacturing entities in nine countries over four continents. The Montreal team, currently four ...

      Read Full Article
    4. Alcon, Carl Zeiss and Bausch & Lomb Lead the European Ophthalmic Device Market to Over €700 million by 2020

      Alcon, Carl Zeiss and Bausch & Lomb Lead the European Ophthalmic Device Market to Over €700 million by 2020

      According to a new report by iData Research ( http://www.idataresearch.com ), the leading global authority in medical device and pharmaceutical market research, the European diagnostic and interventional ophthalmic device market is expected to exceed €700 million by 2020. There are two main drivers fueling this market, technological innovation and the increasingly aging population that are affected with ocular diseases. As the population ages, the prevalence of ocular diseases such as cataracts and glaucoma increases. In addition, refractive problems such as myopia, hyperopia and astigmatism are more likely to occur in older people. These factors drive demand for specialized ophthalmic ...

      Read Full Article
    5. Fujikura enhances splicing products to support biomedical industries

      Fujikura enhances splicing products to support biomedical industries

      Fujikura Europe, one of the world's leading manufacturers of fibre optic cables and equipment, has used 25 years of experience in the speciality splicing sector to enhance its technologies and products, including the LAZERMaster™ and ARCMaster® series, for use in the biomedical and research industries. Fujikura’s advanced splicing technology includes high-end CO₂ laser heating systems, to enable cleaner splicing with no contamination, no electrodes for low maintenance costs and little or no instability at all. Alongside the new products Fujikura will also be providing engineering and optimisation services in specialty splicing for fibre preparation applications. These include custom ...

      Read Full Article
    6. Michelson Diagnostics to present at EuroMedtech 2014

      Michelson Diagnostics to present at EuroMedtech 2014

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that Chief Executive Officer, Jon Holmes, will be presenting an overview of the Company at the 6 th Annual International Medtech Partnering Conference, EuroMedtech™ 2014, in Linz, Austria, 7-8 May 2014. EuroMedtech is Europe's leading medical technology partnering conference, providing collaboration opportunities to medtech decision makers and investors. The conference provides a platform for innovative companies interested in partnering their technologies or products, initiating strategic alliances, or tapping into the international financing network. In addition, early stage projects and small entrepreneurial ...

      Read Full Article
    7. Voxeleron introduces Orion, advanced optical coherence tomography (OCT) analysis software.

      Voxeleron introduces Orion, advanced optical coherence tomography (OCT) analysis software.

      Voxeleron introduces Orion, advanced optical coherence tomography (OCT) analysis software. Orion is fully-automated soft-ware, rapidly and accurately segmenting seven retinal layers in OCT images. The limited functionality of existing OCT analysis tools has meant that only two or three retinal layers are analyzed, despite the overwhelming evidence for the clinical importance of the inner retinal layers in disease detection and prognosis. Orion address-es exactly this technology gap, providing researchers much needed biomarkers for the early detection and prognosis of ophthalmic and neurological diseases. Orion is device independent, processing data from different OCT vendors. Orion will be featured in two posters ...

      Read Full Article
      Mentions: Voxeleron
    8. What Drives St. Jude Medical to Be More Diversified?

      What Drives St. Jude Medical to Be More Diversified?

      The Cardiovascular Division participates in segments of the vascular and structural heart markets. Fractional Flow Reserve (FFR) and Optical Coherence Tomography (OCT) are two emerging technologies, which provide market opportunities, like the case of the ILUMIEN. This one is a platform that combines Fractional Flow Reserve (FFR) for measuring intra-arterial pressure with intravascular Optical Coherence Tomography (OCT) for a visual look inside arteries

      Read Full Article
      Mentions: St. Jude Medical
    9. Bioptigen Unveils the Envisu IntraSurgical OCT System for Real-time Imaging During Ophthalmic Surgery

      Bioptigen Unveils the Envisu IntraSurgical OCT System for Real-time Imaging During Ophthalmic Surgery

      Bioptigen Inc. today unveiled the Envisu IntraSurgical OCT for real-time imaging during ophthalmic surgical procedures. Key attributes of the Envisu IntraSurgical OCT include a wide, flat scan for accurate structural reproduction, and focal controls that operate independently of the microscope. These innovations will provide the surgeon with maximal versatility to assess surface and sub-surface tissue structures during surgical manipulations. Bioptigen’s Envisu IntraSurgical OCT is modularly designed for compatibility with new and existing operating microscopes to extend the power of OCT to surgical ophthalmology. "This advance brings surgeons one step closer to realizing the full value of intraoperative OCT", said ...

      Read Full Article
    10. Funding boost for Gooch and Housego

      Funding boost for Gooch and Housego

      UK-headquartered Gooch and Housego (G&H) has won £0.8 million in government support via the UK’s Regional Growth Fund (RGF). The company, which says it will use the grant from the Department for Business, Innovation and Skills (BIS) to boost investment in its new systems technology business unit in Torbay, was one of 37 companies selected for RGF support in the fifth round of the competitive fund . In total, the RGF is expected to hand out £3.2 billion to UK businesses over seven years. “The objective is to build a multi-disciplinary team with expertise in mechanical, electronic ...

      Read Full Article
      Mentions: Gooch & Housego
    11. Bioptigen Introduces Image-Guided SDOCT Technology to Advance Preclinical Eye Research

      Bioptigen Introduces Image-Guided SDOCT Technology to Advance Preclinical Eye Research

      Bioptigen announced today the availability of EnFace TM color fundus technology delivering image-guided SDOCT into a single, compact, handheld scan head. The new color fundus system provides multiple, integrated modalities into each of Bioptigen’s Envisu TM preclinical SDOCT systems, producing brilliant, color fundus images captured simultaneously with OCT images. The new color image-guided OCT also complements Bioptigen’s volumetric OCT image visualization, and dynamic 3D tissue flattening capabilities to create a powerful, comprehensive suite of tools designed to meet the exacting needs of the ophthalmic research community. Bioptigen's new Envisu SDOCT scan head featuring integrated color fundus camera ...

      Read Full Article
    12. St. Jude Medical Recognized as Innovative Technology Supplier of the Year by Nation’s Largest Health Care Contracting Organization

      St. Jude Medical Recognized as Innovative Technology Supplier of the Year by Nation’s Largest Health Care Contracting Organization

      St. Jude Medical, Inc . ( STJ ), a global medical device company, was recognized by Novation as the 2013 Innovative Technology Supplier of the Year. Novation members selected the St Jude Medical ILUMIEN™ PCI Optimization System based on their experience using the technology to deliver improved patient outcomes. Novation works with its more than 100,000 members and affiliates to identify innovative technology that improves patient care or reduces the risk of harm to patients or providers, while simultaneously raising the standard of patient care and safety. “Novation’s goals of improving patient outcomes through innovative technology align with our mission at ...

      Read Full Article
    13. Imalux Ceases Operation

      Imalux Ceases Operation

      Imalux Corporation has announced that it has ceased operations due to various challenges to become a profitable on-going business. Imalux Corporation was one of the earliest OCT startup companies and received its first seed funding in 2000. Imalux opened operations in Cleveland Ohio with a strong technology connection to the Institute of Applied Physics in Russia. With the visionary leadership of Paul Amazeen and Felix Feldchtein Imalux developed the Niris product line that offered unique endoscopy imaging capabilities. Niris systems were delivered to customer's worldwide offering physicians the ability to identify structural changes in tissues, guide surgical interventions and ...

      Read Full Article
    14. NIDEK Announces FDA Clearance of the RS-3000 Advance

      NIDEK Announces FDA Clearance of the RS-3000 Advance

      NIDEK, Inc. a global leader in the design, manufacturing, and distribution of ophthalmic equipment, is pleased to announce FDA clearance of the RS-3000 Advance . This premier OCT system incorporating Scanning Laser Ophthalmoscope is designed for comprehensive evaluation of the retina and choroid. The RS-3000 Advance provides exquisite detail of the retinal and choroidal microstructures to assist in clinical diagnosis. Features include the choroidal mode, which allows detailed evaluation of the choroid. A wide area scan of 9 mm x 9 mm ensures excellent overall coverage of the retinal structures. Microsaccades and other involuntary eye movements are compensated by the Tracing ...

      Read Full Article
    15. Positive top line results from clinical trial for diagnosis of basal cell carcinoma using VivoSight OCT

      Positive top line results from clinical trial for diagnosis of basal cell carcinoma using VivoSight OCT

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces positive top line results from the successfully completed multi-centre, prospective clinical trial for the diagnosis of basal cell carcinoma using VivoSight OCT. In the study, over 250 patients with clinically suspicious lesions for basal cell carcinoma were scanned at six centres in Germany. In each case, diagnosis using VivoSight OCT was compared with standard clinical diagnosis with and without dermoscopy. All results were verified by the gold standard of biopsy and histological analysis. Papers by Professor Dr. med. Julia Welzel, Dr. med. Martina ...

      Read Full Article
    16. NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging System

      NinePoint Medical Completes $34 Million Series B Financing to Expand Commercialization of its Breakthrough NvisionVLE™ Imaging System

      NinePoint Medical, Inc. , an emerging leader in the development of medical devices for advanced optical imaging, today announced it has completed a $34 million Series B financing led by Corning Incorporated (NYSE: GLW), along with founding investors Third Rock Ventures and Prospect Venture Partners. The company also announced the addition of three new members to its board of directors: Curt Weinstein from Corning, and independent directors Tom Miller and Mark Stautberg. Proceeds from the financing will support the ongoing commercial launch of the NvisionVLE Imaging System in the U.S., as well as development of the company’s expanded product ...

      Read Full Article
    17. Groundbreaking Zeiss Kit Used in First Eye Surgeries

      Groundbreaking Zeiss Kit Used in First Eye Surgeries

      Combination of optical coherence tomography with surgical microscope gives surgeons 'unprecedented' views. Combination kit used in live surgery A new kind of surgical microscope from Zeiss that features integrated intra-operative optical coherence tomography (OCT) is now being used by ophthalmic surgeons. Said to provide those surgeons with unprecedented views of transparent ocular structures during operations, the visualization tool combines two “gold standard” techniques into a single system for the first time. According to the Germany-based optics and optical technology giant's Meditec subsidiary, as well as being able to see transparent structures of the eye during surgery, surgeons can also ...

      Read Full Article
    18. Ultrafast Laser Systems Are Stepping Up to Meet Industry Needs

      Ultrafast Laser Systems Are Stepping Up to Meet Industry Needs

      The wide spectral bandwidth of ultrafast lasers also is useful in optical coherence tomography, widely used to provide 3-D images of tissue. Here, the very broad spectral output of supercontinuum lasers allows for very high axial resolution imaging in multiple user-defined wavelength bands optimized for the tissue being imaged. “The high power and spectral brightness of supercontinuum lasers also allows for deep-tissue imaging, such as in highly scattering media, or in vivo imaging, where signal levels can be very low,” Seaton said.

      Read Full Article
      Mentions: Fianium
    19. Michelson Diagnostics announces completion of data collection in Vivosight OCT trial for BCC diagnosis

      Michelson Diagnostics announces completion of data  collection in Vivosight OCT trial for BCC diagnosis

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that it has completed scanning and data collection for a large 250-patient, multi-centre, prospective clinical trial of the diagnostic performance of its VivoSight™ OCT scanner in diagnosing superficial basal cell carcinoma (BCC), the most common form of skin cancer. Preliminary results from the trial are to be announced at the American Academy of Dermatology (AAD) Annual meeting in Denver, in March 2014. It is expected that full results will be published in a leading peer-reviewed journal later in the year. The study ...

      Read Full Article
    20. Volcano Corporation Presentation At Barclays Conference To Be Webcast

      Volcano Corporation Presentation At Barclays Conference To Be Webcast

      Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the Barclays Global Healthcare Conference 2014 on Tuesday, March 11. The presentation by John Dahldorf, chief financial officer, will begin at 11:15 a.m., Eastern Daylight Time (8:15 a.m., Pacific Daylight Time). The presentation will be available through the conference website at http://cc.talkpoint.com/barc002/031114a_bc/?entity=52_3HS7I2G and via the company's website at www.volcanocorp.com . Volcano Corporation is ...

      Read Full Article
    21. Volcano Corporation (VOLC) news: Volcano's CEO Discusses Q4 2013 Results

      Volcano Corporation (VOLC) news: Volcano's CEO Discusses Q4 2013 Results

      Our revenue growth occurred despite some difficult macro-environmental challenges during the year, many of which we expect will continue to impact our business in 2014. These include; the continued decline of stable coronary PCIs in the U.S. and Japan, along with constrained healthcare spending in the U.S., greater than anticipated FX headwind in Japan and a moderation of FFR growth rates, continued softness in Axsun telecom sector and product introduction delays by key Axsun Medical ophthalmology customers.

      Read Full Article
    22. Volcano Reports Fourth Quarter Revenues Increase Six Percent On A Constant Currency Basis

      Volcano Reports Fourth Quarter Revenues Increase Six Percent On A Constant Currency Basis

      Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the fourth quarter and all of 2013. For the quarter ended December 31, 2013, Volcano reported revenues of $103.3 million versus revenues of $102.5 million in the same period a year ago. On a constant currency basis, revenues increased six percent year-over-year after adjusting for a negative impact of approximately $5.5 millionfrom foreign currency. Medical segment revenues increased approximately one percent and six percent on a ...

      Read Full Article
    23. Michelson Diagnostics to launch enhanced software for VivoSight OCT scanner

      Michelson Diagnostics to launch enhanced software for  VivoSight OCT scanner

      Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces the launch of its upgraded VivoSight OCT scanner with a new software technology that provides additional features for dermatologists to investigate skin lesions such as non-melanoma skin cancer. The VivoSight OCT scanner enables the dermatologist to see vertical cross-sectional images of sub-surface skin tissue to depths of 1-1.5 mm in high definition, providing the clinician with important information about the type, depth and lateral spread of the skin lesion that is not possible to determine from its surface visual appearance. Our ...

      Read Full Article
    24. Fast diagnostic cancer imaging technique displayed at Photonics West 2014

      Fast diagnostic cancer imaging technique displayed at Photonics West 2014

      One of the numerous technologies and applications being highlighted at Photonics West 2014 was a non-invasive optical imaging system used to quickly obtain images at the cellular level to assist in diagnoses and biopsies. CAReIOCA began in 2012 as a collaborative project funded by the European Commission’s Seventh Framework Programme. The project saw the development of an imaging system with the purpose of providing a medical tool for better localization and analysis of cancer biopsies in the operating room in order to "reduce failure and reoperation rates in pre-operative diagnosis." CAReIOCA’s technical partners, LLTech , CMOSIS, and Adimec collaborated ...

      Read Full Article
      Mentions: LLTech
    25-48 of 863 « 1 2 3 4 5 ... 34 35 36 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. Organizations in the News

    1. (1 articles) Wakayama Medical University
    2. (1 articles) Cardiovascular Research Foundation
    3. (1 articles) FDA
  4. People in the News

    1. (2 articles) Scott Huennekens
    2. (1 articles) Giulio Guagliumi
    3. (1 articles) Takashi Akasaka
    4. (1 articles) Gregg W. Stone
    5. (1 articles) Jonathan D. Oakley
  5. OCT Companies in the News

    1. (4 articles) Volcano Corporation
    2. (2 articles) Boston Scientific
    3. (2 articles) St. Jude Medical
    4. (1 articles) Voxeleron
    5. (1 articles) InfraReDx
    6. (1 articles) Bioptigen
    7. (1 articles) Axsun Technologies